Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R G Wilcox

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
European Heart Journal|November 1, 2001
Availability of on-site catheterization and clinical outcomes in patients receiving fibrinolysis for ST-elevation myocardial infarctionJ Llevadot, R P Giugliano, E M Antman, et al.
Circulation|July 13, 2000
Oral glycoprotein IIb/IIIa inhibition with orbofiban in patients with unstable coronary syndromes (OPUS-TIMI 16) trialC P Cannon, C H McCabe, R G Wilcox, et al.
The American Journal of Cardiology|December 30, 1999
Risk stratification with a point-of-care cardiac troponin T test in acute myocardial infarction. GUSTOIII Investigators. Global Use of Strategies To Open Occluded Coronary ArteriesE M Ohman, P W Armstrong, H D White, et al.
JAMA|March 13, 1996
Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigatorsW D Weaver, H D White, R G Wilcox, et al.
European Heart Journal|February 10, 2000
Geographic variability in outcomes within an international trial of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes. Results from PURSUITK M Akkerhuis, J W Deckers, E Boersma, et al.
Circulation|February 23, 2000
Early percutaneous coronary intervention, platelet inhibition with eptifibatide, and clinical outcomes in patients with acute coronary syndromes. PURSUIT InvestigatorsN S Kleiman, A M Lincoff, G C Flaker, et al.
Circulation|June 7, 2000
Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT InvestigatorsE Boersma, K S Pieper, E W Steyerberg, et al.
Journal of the American College of Cardiology|February 24, 2001
Therapeutic value of eptifibatide at community hospitals transferring patients to tertiary referral centers early after admission for acute coronary syndromes. PURSUIT InvestigatorsA B Greenbaum, R A Harrington, M P Hudson, et al.
Lancet (London, England)|April 12, 2001
Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational studyH D Aronow, E J Topol, M T Roe, et al.
The American Journal of Cardiology|April 24, 1999
Prior aspirin use predicts worse outcomes in patients with non-ST-elevation acute coronary syndromes. PURSUIT Investigators. Platelet IIb/IIIa in Unstable angina: Receptor Suppression Using Integrilin TherapyJ H Alexander, R A Harrington, R H Tuttle, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
European Heart Journal|November 1, 2001
Availability of on-site catheterization and clinical outcomes in patients receiving fibrinolysis for ST-elevation myocardial infarctionJ Llevadot, R P Giugliano, E M Antman, et al.
Circulation|July 13, 2000
Oral glycoprotein IIb/IIIa inhibition with orbofiban in patients with unstable coronary syndromes (OPUS-TIMI 16) trialC P Cannon, C H McCabe, R G Wilcox, et al.
The American Journal of Cardiology|December 30, 1999
Risk stratification with a point-of-care cardiac troponin T test in acute myocardial infarction. GUSTOIII Investigators. Global Use of Strategies To Open Occluded Coronary ArteriesE M Ohman, P W Armstrong, H D White, et al.
JAMA|March 13, 1996
Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigatorsW D Weaver, H D White, R G Wilcox, et al.
European Heart Journal|February 10, 2000
Geographic variability in outcomes within an international trial of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes. Results from PURSUITK M Akkerhuis, J W Deckers, E Boersma, et al.
Circulation|February 23, 2000
Early percutaneous coronary intervention, platelet inhibition with eptifibatide, and clinical outcomes in patients with acute coronary syndromes. PURSUIT InvestigatorsN S Kleiman, A M Lincoff, G C Flaker, et al.
Circulation|June 7, 2000
Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT InvestigatorsE Boersma, K S Pieper, E W Steyerberg, et al.
Journal of the American College of Cardiology|February 24, 2001
Therapeutic value of eptifibatide at community hospitals transferring patients to tertiary referral centers early after admission for acute coronary syndromes. PURSUIT InvestigatorsA B Greenbaum, R A Harrington, M P Hudson, et al.
Lancet (London, England)|April 12, 2001
Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational studyH D Aronow, E J Topol, M T Roe, et al.
The American Journal of Cardiology|April 24, 1999
Prior aspirin use predicts worse outcomes in patients with non-ST-elevation acute coronary syndromes. PURSUIT Investigators. Platelet IIb/IIIa in Unstable angina: Receptor Suppression Using Integrilin TherapyJ H Alexander, R A Harrington, R H Tuttle, et al.
Pageof 8